The identification of S6K1 as a potential therapeutic target in oncology is supported by the fact that the S6K1 gene (RPS6KB1) is located at human chromosome 17q23, a region that is amplified in 20% of primary breast cancers as measured by comparative genomic hybridisation [9]. This evidence concerns the gene RPS6KB1 and breast cancer.